US Hospitals Slow to Adopt Newer Antibiotics for Highly Resistant Infections
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Tag: NIH/NIAID
All
Latest
All
Latest
Blood Test Can Quickly Diagnose Sarcoidosis
Researchers have developed a tool to rapidly and inexpensively diagnose sarcoidosis using a simple blood test.
All
Latest
Adenotonsillectomy Benefits Kids with Mild Sleep Apnea, Study Shows
Surgical removal of the tonsils and adenoids in children with snoring and mild breathing problems during sleep appears to improve their sleep, quality of life, and blood pressure a year after surgery.
NIH Trial of Six-Strain Universal Flu Vaccine Candidate Begins
The nanoparticle vaccine candidate, FluMos-v2, builds on its predecessor FluMos-v1 and is designed to induce antibodies against six flu strains.
Read More
Children in High-Opportunity Neighborhoods Less Likely to Develop Asthma
Living in a neighborhood with better access to resources during the early stages of childhood was associated with lower asthma incidence in a new study from the NIH’s Environmental influences on Child Health Outcomes program.
Read More
Metals in Water Linked to Increased Lung Infections in Cystic Fibrosis
An NIH study found high levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria pulmonary infections in people with cystic fibrosis.
Read More
COVID-19 Boosters in Pregnancy Increase Immunity for Mom and Baby
An NIH-funded study supports the use of COVID-19 vaccination and, in particular, booster doses during pregnancy.
Read More
NIH Launches Long COVID Clinical Trials
The National Institutes of Health has opened enrollment for Phase 2 clinical trials to evaluate at least four potential treatments for long COVID.
Read More
Clinical Trial of mRNA Universal Flu Vaccine Candidate Begins
The phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.
Read More
Biological Mechanisms of Long COVID Neurological Symptoms Identified
Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health and were found to have differences in their immune cell profiles and autonomic dysfunction.
Read More
NIH Recognizes World Asthma Day 2023
Today, the National Institutes of Health recognizes World Asthma Day and the innovative research that is helping to shed light on the disease, pave the way for effective treatments, and improve the lives of people who have asthma.
Read More
NIAID’s Universal Flu Vaccine Candidate Advances to Second Trial
In a phase 1 clinical trial, the vaccine developed by NIAID’s Vaccine Research Center was safe, well-tolerated, and induced broad antibody responses that target the hemagglutinin stem.
Read More
National Cancer Institute Launches Pragmatica-Lung Study
The National Cancer Institute has helped launch the phase 3 Pragmatica-Lung Study to assess a two-drug combination to treat patients with advanced non-small cell lung cancer (NSCLC).
Read More
Eight Grants to Fund Rapid Diagnosis of MIS-C
Eight NIH grants will fund research to refine new technologies for rapid diagnosis of multisystem inflammatory syndrome in children (MIS-C).
Read More
NIH Harm Reduction Research Network Targets Opioid Overdose Fatalities
Harm reduction is an evidence-based, often life-saving approach that directly engages people who use drugs to prevent overdose, disease transmission and other harms.
Read More